Study sheds new light on p53 tumor suppressor gene’s role in ulcerative colitis

Researchers in the lab of Michael Sigal at the Max Delbrück Center and Charité – Universitätsmedizin Berlin have elucidated the role of the p53 gene in ulcerative colitis.

Novel approach sheds light on the interactions between SARS-CoV-2 viruses and human placenta

Until now, scientific evidence has been inconclusive regarding the ability of SARS-CoV-2, the virus that causes COVID, to replicate in the human placenta.

July 8, 2023

Amylyx ALS drug failure leaves patients, advocates, and researchers reeling — and wondering what’s next

The latest disappointment in amyotrophic lateral sclerosis research brought crushing news for patients and physicians, forcing the community to consider just what to do with

March 8, 2024

Like Gilead, AbbVie gets its tentacles into pact with Tentarix

The octopi at Tentarix Biotherapeutics are celebrating this morning. AbbVie plans to pay $64 million upfront for two programs out of the San Diego biotech’s

February 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.